Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.47 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27609913 | 0.86 | CA1 (0.46) | PTGS1CA1CA2HIF1ALMNA | |
| SCHEMBL7102472 | 0.84 | PTGS2 (0.47) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL153695 | 0.83 | PTGS2 (0.59) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL3290293 | 0.82 | HPGD (0.50) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL10483833 | 0.82 | CXCL8 (0.46) | PTGS1CXCL8CA1CA2HIF1A | |
| SCHEMBL2731013 | 0.82 | PTGS2 (0.57) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL490949 | 0.82 | PTGS2 (0.49) | PTGS2PTGS1CXCL8LMNATSHR | |
| Methane SCHEMBL17958768 | 0.82 | PTGS2 (0.57) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL286787 | 0.81 | CXCL8 (0.43) | PTGS2PTGS1CXCL8CA1CA2 | |
| SCHEMBL6248977 | 0.81 | MMP2 (0.48) | PTGS2PTGS1CXCL8CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157854-A | Preparation method for synthesizing ADHC-based homopolyester based on dihydroxyaromatic acid carbonate | 沈阳工业大学 | 2025-06-17 | — | — | CN | claimed |
| US-20250012780-A1 | Application of Organic Acids in Urine for Health Management | OU YUNG CHUN (TW) | 2025-01-09 | — | — | US | claimed |
| CN-119269659-A | Application of urine organic acid in health management | 欧湧淳 | 2025-01-07 | — | — | CN | claimed |
| CN-118367119-A | Organic matter modified carbon-based negative electrode material and manufacturing method thereof | 贵州创德新能源科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-4206236-A1 | COMPOUNDS, THEIR SYNTHESIS AND COMPOSITIONS COMPRISING THE COMPOUNDS FOR ENHANCED DEPOSITION OF POLYMERS ONTO HAIR SURFACES | Kao Corporation (JP) | 2023-07-05 | — | — | EP | claimed |
| CN-114177359-B | Antibacterial coating and preparation method and application thereof | 广东省科学院健康医学研究所 | 2023-03-24 | — | — | CN | claimed |
| CN-112210091-B | Multifunctional natural polysaccharide repairing adhesive hydrogel, preparation method and application of multifunctional natural polysaccharide repairing adhesive hydrogel in preparation of medicines for treating skin injury | 吉林大学 | 2021-08-10 | — | — | CN | claimed |
| CN-112210091-A | Multifunctional natural polysaccharide repairing adhesive hydrogel, preparation method and application of multifunctional natural polysaccharide repairing adhesive hydrogel in preparation of medicines for treating skin injury | 吉林大学 | 2021-01-12 | — | — | CN | claimed |
| CN-109705504-B | Preparation method of modified polytetrafluoroethylene powder | 浙江巨化技术中心有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-110917661-B | Method for treating oil-in-water emulsion by using positive electricity enhanced oleophylic hydrophobic three-dimensional porous material | 同济大学 | 2020-12-18 | — | — | CN | claimed |
| WO-2013063204-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-05-02 | — | — | WO | claimed |
| WO-2013016668-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC. (US) | 2013-01-31 | — | — | WO | claimed |
| US-20120142720-A1 | Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof | KEMPHARM, INC. (US) | 2012-06-07 | — | — | US | claimed |
| EP-2448408-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF | Kempharm, Inc. (US) | 2012-05-09 | — | — | EP | claimed |
| US-20110137235-A1 | ULTRASONIC CANCER THERAPY ACCELERATOR | TOTO LTD. (JP) | 2011-06-09 | — | — | US | claimed |
| EP-2298327-A1 | ANTI-TUMOR AGENT | Toto Ltd. (JP) | 2011-03-23 | — | — | EP | claimed |
| WO-2011002995-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2011-01-06 | — | — | WO | claimed |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2011-01-06 | — | — | US | claimed |
| US-20090297620-A1 | Anti-Tumor Agent | TOTO LTD. (JP) | 2009-12-03 | — | — | US | claimed |
| US-5686311-A | ANALYZING FLUID SAMPLE | THE CHILDREN'S MERCY HOSPITAL (US) | 1997-11-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142720-A1 | Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof | CYP7A1, CYP2B6, CYP2D6 | PTGS2 389/4885PTGS1 154/4885CXCL8 1991/4885 |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | CYP7A1, CYP2B6, CYP2D6 | PTGS2 393/4885PTGS1 157/4885CXCL8 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.